An article that appears online today entitled: "Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's Disease" scheduled for the September 17 edition of Cell, the prestigious peer-reviewed, international biological research journal is published.
Link:http://www.pranabio.com/downloads/Media%20Releases/Media%20Release%202010/Prana%20in%20Cell%203%20Sept%202010.pdf
Source:Prana

The initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog(R), and insulin lispro, the active ingredient in Humalog(R) was announced.
Link:http://phx.corporate-ir.net/phoenix.zhtml?c=175436&p=irol-newsArticle&ID=1466263&highlight=
Source:Halozyme

The European Commission has granted marketing authorisation for its lead product, PecFent, an innovative fentanyl nasal spray for the treatment of breakthrough cancer pain (BTCP) in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
Link:http://www.archimedespharma.com/newseventsNews.html
Source:Archimedes

Aggressively lowering blood pressure did little to prevent kidney damage in blacks, unless protein in their urine showed evidence of damage in the first place, researchers reported on Wednesday.
It is reported in the New England Journal of Medicine.
Link:http://www.reuters.com/article/idUSTRE68070W20100901
Source:Reuters

A Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections has been completed.
Link:http://www.ir-site.com/images/library/master/edgar/story.aspx?symbol=INHX&story=33659185
Inhibitex

An antibiotic, A3-APO that gets its microbe-fighting power from insect proteins was effective at attacking a common infection that afflicts blast victims in war zones, U.S. researchers said on Wednesday.
It is published in Journal of Antimicrobial Chemotherapy, online September 1.
Link:http://www.reuters.com/article/idUSTRE6805C420100901
Source:Reuters

An altered version of the cancer drug Gleevec, imatinib could form the basis of a new class of drugs that block the development of brain-damaging plaques in Alzheimer's disease, U.S. researchers said on Wednesday.
It is published in the journal Nature.
Link:http://www.reuters.com/article/idUSTRE6805J520100901
Source:Reuters

Scientists studying the autoimmmune disease lupus have found that blood platelets are key in its development and say their findings in the lab suggest blood-thinning drug, Plavix known generically as clopidogrel may offer a new way to treat patients.
It is published in the Science Translational Medicine Journal on Wednesday.
Link:http://www.reuters.com/article/idUSTRE6805T320100901
Source:Reuters

The common diabetes drug metformin may hold promise as a way to keep smokers from developing lung cancer, U.S. researchers said on Wednesday.
The findings were published in the journal Cancer Prevention Research.
Link:http://www.reuters.com/article/idUSTRE68070P20100901
Source:Reuters

A study in the Sept. 1 issue of the journal SLEEP found an elevated risk of death in men with a complaint of chronic insomnia and an objectively measured short sleep duration. The results suggest that public health policy should emphasize the diagnosis and appropriate treatment of chronic insomnia.
Link:http://www.eurekalert.org/pub_releases/2010-09/aaos-sfa082610.php
Source:EurekAlert